Cargando…
Targeting the gastrin-releasing peptide receptor pathway to treat cognitive dysfunctionassociated with Alzheimer’s Disease
Increasing evidence indicates that bombesin (BB)-like peptides (BLPs), such as the gastrin-releasing peptide (GRP) and its receptor (GRPR), might play a role in neurological and psychiatric disorders. The present study reviews findings from animal and human studies suggesting that the GRPR should be...
Autores principales: | Roesler, Rafael, Luft, Tatiana, Schwartsmann, Gilberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação de Neurologia Cognitiva e do
Comportamento
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619558/ https://www.ncbi.nlm.nih.gov/pubmed/29213377 http://dx.doi.org/10.1590/s1980-57642008dn10200002 |
Ejemplares similares
-
Gastrin-releasing peptide receptors in the central nervous system: role in brain function and as a drug target
por: Roesler, Rafael, et al.
Publicado: (2012) -
Gastrin-releasing peptide receptor antagonist induces a protection from lethal sepsis: involvement of toll-like receptor 4 signaling
por: Petronilho, F, et al.
Publicado: (2010) -
RC-3095, a Selective Gastrin-Releasing Peptide Receptor Antagonist, Does Not Protect the Lungs in an Experimental Model of Lung Ischemia-Reperfusion Injury
por: Oliveira-Freitas, Vera L., et al.
Publicado: (2015) -
Nanostrategies for Therapeutic and Diagnostic Targeting of Gastrin-Releasing Peptide Receptor
por: Rurarz, Beata Paulina, et al.
Publicado: (2023) -
Human gastrin- releasing peptide receptor expression in women with uterine cervix cancer
por: Kunos, Charles A., et al.
Publicado: (2023)